EASL Podcasts

What do we call it when someone with high-risk practices becomes viraemic again after treatment? In this episode, experts discuss the challenges of managing Hepatitis C in people who inject drugs (PWID) and other high-risk groups. Topics include SVR confirmation rates, DAA prescribing practices, acute vs. chronic infection, and real-world reinfection data. Are traditional labels still meaningful o...

In hepatology, effective care goes beyond diagnostics and treatment. This episode explores the crucial questions hepatologists should ask to truly understand their patients’ needs, values, and priorities. By focusing on communication and patient-centred care, our experts highlight how listening carefully can improve adherence, enhance quality of life, and ultimately lead to better outcomes. Modera...

This first session in a two-part EASL DeepDive series on the 2024 EASL-EASD-EASO MASLD Clinical Practice Guidelines will provide a detailed examination of the recommendations concerning diagnosis, non-invasive assessment, and risk stratification, with a view to supporting evidence-based clinical practice. Learning objectives Have a good understanding of the concept/definition of MASLD within the f...

This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms,...

In this new edition of the EASL DeepDive, expert faculty guide participants through a focused and forward-looking discussion on key aspects of advanced MASLD, setting the stage for a deeper understanding of evolving clinical challenges and opportunities. This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive. Le...

This EASL Studio episode explores state-of-the-art practices in diagnosing steatotic liver disease and stratifying patients effectively for targeted treatment in 2025. Focusing on integrating cardiometabolic risk profiling and dynamic alcohol consumption assessment, the discussion will discuss contemporary methods, frequency, and practical implementation in clinical settings to enhance precision m...

Listen to this EASL Studio episode to explore how artificial intelligence (AI) is transforming healthcare. Discuss its potential to revolutionise medical practice, its limitations, and whether it poses a threat or an opportunity for the future of the medical profession. Moderator: Ahmed Elsharkawy   Faculty: Jakob Kather, Sabela Lens, Ashley Spann  Related episodes: EASL Studio at EASL Congress 20...

With the release of the new HBV guidelines, treatment eligibility broadens. This EASL Studio explores how to communicate these changes, support shared decision-making, ensure adherence, and engage patients in ongoing care and clinical trials. Moderator: Ahmed Elsharkawy  Faculty: Markus Cornberg, Sital Shah, Thomas Tu, Su Wang This EASL Studio is supported by Aligos Therapeutics, GSK and Gilead Sc...

Listen to this EASL Studio episode for insights on the new MASLD guidelines and their practical application. Hear from experts on navigating the nomenclature change, implementing guidelines in clinical workflows, and fostering behavioral change to improve patient outcomes across the care team. Moderator: Sven Francque  Faculty: Marta Cervera, Elena George, Shelley Keating This programme is part of...

What happens when hepatologists and interventional radiologists join forces? This episode discusses the power of collaboration – shared guidelines, joint training, and multidisciplinary care – to improve outcomes in complex liver disease. Moderator: Sven Francque Faculty: Irene Bargellini, Virginia Hernández-Gea, Max Seidensticker All EASL Studio Podcasts are available on EASL Campus . Click here...

This EASL Studio episode cuts through the noise to explore alcohol’s true impact on health and society, spotlighting patient stories, public misconceptions, and bold policy solutions from across Europe. Moderator: David Barret (Internal Communications and Multimedia Manager, WHO Regional Office for Europe) Faculty: Carina Ferreira-Borges (Regional Advisor for Alcohol, Illicit drugs and Prison heal...

Most liver diseases are diagnosed when it’s already too late. This episode explores the pros and cons of early screening, the gaps in current strategies, and how projects like LIVERAiM are aiming to change the game. Moderator: Ahmed Elsharkawy Faculty: Pere Ginès, Ian Rowe, Maja Thiele All EASL Studio Podcasts are available on EASL Campus . Click here to see all EASL Video Podcasts on Apple Podcas...

Listen to this episode for a curated overview of landmark studies and breakthrough data presented at EASL Congress 2025, with expert insights on their clinical relevance and impact on the future of hepatology. Moderator: Thomas Berg  Faculty: Hannes Hagström, Verena Keitel, Raj Mookerjee All EASL Studio Podcasts are available on EASL Campus . Click here to see all EASL Video Podcasts on Apple Podc...

In this fifth edition of the EASL DeepDive, join Christophe Bureau, Virginia Hernandez-Gea, Marika Rudler, and Manhal Izzy to gain expert insight into the selection, management, and outcomes of patients undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures. This EASL DeepDive webinar is supported by W. L. Gore & Associates. W. L. Gore & Associates has had no input into...

This EASL Studio episode discusses cutting-edge approaches for managing bleeding varices. Explore the evolution of endoscopic therapies, the role of interventional radiology, and decision-making for high-risk gastric varices. Gain insights into EUS-guided portal pressure assessment and its impact on tailoring treatment strategies. Moderator: Debbie Shawcross Faculty: Wim Laleman, David Patch Relat...

In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient managem...

In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus. Learning objectives Discover the latest mechanistic insights relating to the occurrence of PBC symptoms Learn more about the holistic management of PBC symptoms, with a particular em...

In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency. Learning objectives: Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcohol Get a better understan...

In this EASL DeepDive held on 25 February 2025,  Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC. Learning objectives Learn more about the molecular mechanisms underlying the disease and the...

This episode celebrates 40 years of the Journal of Hepatology, EASL’s flagship journal. Tune in to discover how far we’ve come—and what’s next for the journal. Moderator: Thomas Berg  Faculty: Paolo Angeli, Annalisa Berzigotti, Rajiv Jalan, Vlad Ratziu, Frank Tacke and Jessica Zucman-Rossi All EASL Studio Podcasts are available on EASL Campus . Click here to see all EASL Video Podcasts on Apple Po...

Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper . Join us to uncover how these advancements can address key hurdles in managing these rare malignancies. Read the position paper:...

This episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in cancer-related labelling, and understanding the influence of social norms on adolescent alcohol consumption. Learn from successful alcohol policy implement...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’s Day , this EASL Studio episode debates the molecular, hormonal, and genetic mechanisms driving these disparities. Moderator : Saskia van Mil Faculty : Sara Della Torre and Münevver Demir Related episode S...

Tune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder. Moderator : Debbie Shawcross Faculty : Aftab Ala, Zoe Mariño and Thomas Sandahl This EASL Studio is supported by Orphalan and Univar Solutions. EASL has received no input...

Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes. Moderator : Thomas Berg Faculty : Tim Greten and Anna Saborowski This EASL Studio is suppo...